Douglas Yee

26PUBLICATIONS
116CO-AUTHORS
Molecular targetsCancer geneticsTumour immunologyMedical devicesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Sep 02, 2026
Engineering isoform-selective miniprotein binders to the fetal form of the insulin receptor.

|Jul 08, 2026
mRNA and protein expression of fetal insulin receptor in breast cancer cell lines and tissues.

|Mar 20, 2026
Tumor-specific lncRNA IGF1R-AS1 trans-regulates chromatin interactions associated with oncogenic MYC signaling.

Yongyong Yang, Ting-You Wang, Joshua Fry

|Dec 31, 2025
mRNA and Protein Expression of Fetal Insulin Receptor in Breast Cancer Cell Lines.

Xihong Zhang, Albert Barrios, LeeAnn Higgins

|Sep 04, 2025
Immune and Growth Factor Signaling Pathways Are Associated with Pathologic Complete Response to an Anti-Type I Insulin-like Growth Factor Receptor Regimen in Patients with Breast Cancer.

Emmanuel F Petricoin, Denise M Wolf, Christina Yau

|Jun 17, 2025
Immune Subtyping Identifies Patients With Hormone Receptor-Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 Trial.

Denise M Wolf, Christina Yau, Michael Campbell

Pageof 5

Frequent Collaborators

9 joint publications

Gillian L Hirst

9 joint publications

Laura Van't Veer

8 joint publications

Laura J Esserman

8 joint publications

Lamorna Brown-Swigart